Delivery Order SPE2DB20D2014-SPE2DB25FC96G
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $33,203.38 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (500-count units). This competitive, firm fixed-price delivery order was executed on August 21, 2025, with an ultimate completion date of August 22, 2025. The contract does not carry a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100 count) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order has a ceiling value of $27,735.62 and carries no set-aside designation. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at approximately $27,938 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100-count units) on August 25, 2025, with completion targeted for August 26, 2025. This non-set-aside, competitively awarded delivery order reflects a firm fixed-price contract structure and will be performed at the vendor's facility in Conshohocken, Pennsylvania. CellCept (mycophenolate mofetil) is an immunosuppressant medication...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of CellCept 500 mg tablets (100-count units) valued at $7,015.33. This firm fixed-price delivery order, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive award supporting federal pharmaceutical procurement needs. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $35,063.75 to AmerisourceBergen Drug Corp for 100 tablets of CellCept 500 mg, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order under a larger contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of CellCept 500 mg tablets (500-count bottles) under a firm fixed-price contract with a ceiling value of $13,051.42. The delivery order, which is not set-aside, is scheduled for completion by July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,296.81 to AmerisourceBergen Drug Corp for the supply of 100 capsules of CellCept 250 mg medication. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 9, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,577.14 to AmerisourceBergen Drug Corp for the supply of CellCept 250 mg capsules (100 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. CellCept (mycophenolate mofetil) is an immunosuppressant medication commonly...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitively awarded delivery order (Contract No. 4568982464) by the Defense Logistics Agency on August 4, 2025, for the supply of CellCept 500 mg tablets in a quantity of 100 units. This firm fixed-price delivery order carries a ceiling value of $7,817.19 and is scheduled for ultimate completion by August 5, 2025. The contract carries no set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 mg CellCept vials valued at $1,014.42 under firm fixed-price terms. This non-set-aside competitive award was executed on September 2, 2025, with an ultimate completion date of September 3, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a routine transaction within the...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC96GDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CellCept 500 mg tablets (500-count) with a ceiling value of $8,422.33 under a firm fixed-price contract type. The award was made on September 10, 2025, with an ultimate completion date of September 11, 2025, and was not designated as a set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies to military healthcare systems worldwide. CellCept is an immunosuppressant medication commonly used in federal healthcare programs, and this delivery order exemplifies the routine pharmaceutical procurement activities conducted under the larger prime vendor contract that supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 9/10/25 |